查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869783

北美、欧洲和亚太地区基因治疗细胞培养基市场规模、份额和趋势分析报告：按产品类型、载体类型、最终用户、地区和细分市场预测（2026-2033 年）

North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Size, Share & Trends Analysis Report By Product (Specialty Media, Serum-free Media), By Vector Type (AAV, LV), By End User, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

北美、欧洲和亚太地区基因治疗细胞培养基市场摘要

2025年，北美、欧洲和亚太地区基因治疗细胞培养基市场规模估计为4.383亿美元，预计2033年将达到15.338亿美元。

预计2026年至2033年，北美、欧洲和亚太地区的基因治疗细胞培养基市场将以17.08%的复合年增长率成长。推动该市场成长的主要因素包括临床试验活动的增加、生物製造能力的提升以及对符合GMP规范、化学成分明确的培养基日益增长的需求。这些地区正在加速采用高性能培养基，以提高载体产量并简化生产流程。

罕见遗传疾病治疗的进展和强有力的监管支持

开发罕见遗传疾病治疗方法的迫切需求是基因治疗细胞培养基市场成长要素。虽然在美国，每种罕见疾病影响的人数不足20万，但全球约有7000种罕见疾病，总合影响超过2500万美国。许多此类疾病是由单一基因突变引起的，因此特别适合采用基因疗法来纠正或替换缺陷基因。与仅能控制症状的疗法不同，基因疗法可望提供长期疗效，有时甚至根治性疾病。然而，要实现这一目标需要专门的培养基。研究人员和生产者需要无血清、化学成分明确的培养基，以支持脆弱细胞在从早期实验室工作到临床前试验和大规模临床生产的各个开发阶段。标准的通用培养基通常无法满足需求，因此需要针对敏感细胞和患者来源细胞类型量身定制的解决方案。

同时，监管政策的改善也使该领域更具投资吸引力。许多国家目前提供加速核准、税收优惠、延长市场独占期或直接资助等项目，旨在降低开发针对小众患者群体治疗方法的风险。儘管这些激励措施因地区而异，但它们都支持一个通用的目标：使罕见疾病治疗在经济上可行，并让有需要的患者能够获得治疗。科学研究机会与监管支援的结合，为生物製药公司和契约製造创造了一个极具吸引力的环境，使他们能够投入人才和资源，开发扩充性的高性能培养基解决方案。随着罕见疾病计画的扩展，对可靠的客製化培养基的需求将持续增长，从而巩固其在基因和细胞治疗未来发展中的核心地位。

目录

第一章调查方法和范围

第二章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 补贴市场展望
  • 市场趋势与展望
  • 市场动态
    • 市场驱动因素的影响分析
    • 市场限制因素的影响分析
  • 商业环境分析
    • PESTLE分析
    • 波特五力分析

第四章 产品业务分析

  • 产品细分仪表板
  • 北美、欧洲和亚太地区基因治疗细胞培养基市场：产品及变异分析
  • 北美、欧洲及亚太地区基因治疗细胞培养基市场规模及趋势分析（依产品分类，2021-2033 年）
  • 专业领域
  • 无血清培养基
  • 古典媒介
  • 其他的

第五章 向量商业分析

  • 向量细分仪表板
  • 北美、欧洲和亚太地区基因治疗细胞培养基市场：载体类型和变异分析
  • 北美、欧洲及亚太地区基因治疗细胞培养基市场规模及趋势分析（依载体类型划分，2021-2033 年）
  • AAV製作
  • LV 生产
  • 其他向量

第六章：最终用户业务分析

  • 最终用户细分仪表板
  • 北美、欧洲和亚太地区基因治疗细胞培养基市场的终端用户和波动性分析
  • 北美、欧洲和亚太地区基因治疗细胞培养基市场规模及趋势分析（按最终用户划分，2021-2033 年）
  • 製药和生物技术公司
  • 合约研发生产力组织（CDMO）和合约研究组织（CRO）
  • 研究和学术机构

7. 北美、欧洲和亚太地区基因治疗细胞培养基市场：按产品、载体类型和最终用途分類的区域估算和趋势分析

  • 区域仪錶板
  • 市场规模、预测与趋势分析，2021-2033年
  • 北美洲
    • 2021-2033年北美基因治疗细胞培养基市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2021-2033年欧洲基因治疗细胞培养基市场
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区：北美、欧洲和亚太地区基因治疗细胞培养基市场，2021-2033年
    • 日本
    • 中国
    • 印度
    • 新加坡
    • 澳洲
    • 泰国
    • 韩国

第八章 竞争情势

  • 公司分类
  • 策略规划
  • 企业市场分析，2025年
  • 公司简介/上市公司
    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Merck KGaA
    • Lonza
    • Danaher Corporation（Cytiva）
    • FUJIFILM Holdings Corporation
    • MP Biomedicals
    • Corning Incorporated
    • PAN-Biotech
    • Bio-Techne（R&D Systems, Inc.）
    • InVitria Inc.
    • Florabio AS
    • Revvity
    • Virica
Product Code: GVR-4-68040-762-6

North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Summary

The North America, Europe & Asia Pacific gene therapy cell culture media market size was estimated at USD 438.3 million in 2025 and is expected to reach a value of USD 1,533.8 million by 2033, growing at a CAGR of 17.08% from 2026 to 2033. The gene therapy cell culture media market in North America, Europe, and the Asia Pacific is driven by rising clinical trial activity, expanding biomanufacturing capacity, and the growing need for GMP-compliant, chemically defined media. Together, these regions are accelerating the adoption of high-performance media to boost vector yields and streamline production.

Growth In Rare Genetic Disease Therapies And Strong Regulatory Support

The push to develop therapies for rare genetic disorders has become a major driver in the gene therapy cell culture media market. Although each rare disease affects fewer than 200,000 people in the U.S., there are nearly 7,000 such conditions worldwide, collectively impacting more than 25 million Americans. Many of these disorders stem from single-gene mutations, which makes them especially suitable for gene therapy approaches that correct or replace faulty genes. Unlike treatments that only manage symptoms, gene therapy has the potential to offer long-term, sometimes even curative outcomes. Achieving this, however, depends on specialized culture media. Researchers and manufacturers need serum-free, chemically defined formulations that can nurture fragile cells across every stage of development from early lab work to preclinical studies and full-scale clinical production. Standard, one-size-fits-all media often falls short, creating demand for tailored solutions for sensitive or patient-derived cell types.

At the same time, regulatory policies are making this field more attractive for investment. Many countries now offer programs that fast-track approvals, grant tax breaks, extend market exclusivity, or provide direct funding, all aimed at reducing the risk of working on therapies for small patient populations. While these incentives vary by region, they all support the same idea of making treatments for rare diseases financially viable and available to the patients who need them. This blend of scientific opportunity and regulatory support is evolving the landscape to make it attractive for biopharma companies and contract manufacturers to invest talent and resources into developing scalable and high-performing media solutions. As rare disease programs expand, the need for reliable, customized culture media will only grow, reinforcing its central role in the future of gene and cell therapies.

North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the North America, Europe & Asia Pacific gene therapy cell culture media market on the basis of product, vector type, end user, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Specialty Media
  • Serum-free Media
  • Classical Media
  • Others
  • Vector Type Outlook (Revenue, USD Million, 2021 - 2033)
  • AAV Production
  • LV Production
  • Other Vectors
  • End User Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical and Biotechnology Companies
  • Contract Development & Manufacturing Organizations (CDMOs) & CROs
  • Research and Academic Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Vector Type
    • 1.2.3. End User
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Impact Analysis
      • 3.3.1.1. Increasing biobanking activities
      • 3.3.1.2. Increasing capacity for viral vector production
      • 3.3.1.3. Growth in rare genetic disease therapies and strong regulatory support
    • 3.3.2. Market Restraint Impact Analysis
      • 3.3.2.1. Technical and manufacturing challenges
      • 3.3.2.2. Long development timelines
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Product, Movement Analysis
  • 4.3. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Specialty Media
    • 4.4.1. Specialty Media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Serum-free Media
    • 4.5.1. Serum-free media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Classical Media
    • 4.6.1. Classical media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others media market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Vector Type Business Analysis

  • 5.1. Vector Type Segment Dashboard
  • 5.2. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Vector Type, Movement Analysis
  • 5.3. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Size & Trend Analysis, by Vector Type, 2021 to 2033 (USD Million)
  • 5.4. AAV Production
    • 5.4.1. AAV production market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. LV Production
    • 5.5.1. LV production market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Other Vectors
    • 5.6.1. Other vectors market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End User Business Analysis

  • 6.1. End User Segment Dashboard
  • 6.2. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market End User, Movement Analysis
  • 6.3. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market Size & Trend Analysis, by End User, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Contract Development & Manufacturing Organizations (CDMOs) & CROs
    • 6.5.1. Contract development & manufacturing organizations (CDMOs) & CROs market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Research and Academic Institutes
    • 6.6.1. Research and academic institutes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market: Regional Estimates and Trend Analysis, by Product, Vector Type, & End User

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. U.S. gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Canada gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Mexico gene therapy cell culture media market, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. UK gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Germany gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. France gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Italy gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Spain gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Denmark gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. Sweden gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Target Disease Prevalence
      • 7.4.9.3. Competitive Scenario
      • 7.4.9.4. Regulatory Framework
      • 7.4.9.5. Norway gene therapy cell culture media market, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific North America, Europe & Asia Pacific gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Japan gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. China gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. India gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.5. Singapore
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Singapore gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Regulatory Framework
      • 7.5.6.5. Australia gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Regulatory Framework
      • 7.5.7.5. Thailand gene therapy cell culture media market, 2021 - 2033 (USD Million)
    • 7.5.8. South Korea
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Target Disease Prevalence
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Regulatory Framework
      • 7.5.8.5. South Korea gene therapy cell culture media market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Sartorius AG
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Danaher Corporation (Cytiva)
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. FUJIFILM Holdings Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. MP Biomedicals
      • 8.4.7.1. Overview
      • 8.4.7.2. Product Benchmarking
      • 8.4.7.3. Strategic Initiatives
    • 8.4.8. Corning Incorporated
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. PAN-Biotech
      • 8.4.9.1. Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. Bio-Techne (R&D Systems, Inc.)
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. InVitria Inc.
      • 8.4.11.1. Overview
      • 8.4.11.2. Product Benchmarking
      • 8.4.11.3. Strategic Initiatives
    • 8.4.12. Florabio AS
      • 8.4.12.1. Overview
      • 8.4.12.2. Product Benchmarking
      • 8.4.12.3. Strategic Initiatives
    • 8.4.13. Revvity
      • 8.4.13.1. Overview
      • 8.4.13.2. Financial Performance
      • 8.4.13.3. Product Benchmarking
      • 8.4.13.4. Strategic Initiatives
    • 8.4.14. Virica
      • 8.4.14.1. Overview
      • 8.4.14.2. Product Benchmarking
      • 8.4.14.3. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 5 North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market, end user, 2021 - 2033 (USD Million)
  • Table 6 North America, Europe & Asia Pacific Gene Therapy Cell Culture Media Market, by region, 2021 - 2033 (USD Million)
  • Table 7 North America Gene Therapy Cell Culture Media Market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 9 North America Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 10 North America Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 11 U.S. Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 12 U.S. Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 13 U.S. Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 14 Canada Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 15 Canada Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 16 Canada Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 17 Mexico Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 18 Mexico Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 19 Mexico Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 20 Europe Gene Therapy Cell Culture Media Market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 22 Europe Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 23 Europe Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 24 Germany Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 25 Germany Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 26 Germany Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 27 UK Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 28 UK Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 29 UK Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 30 France Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 31 France Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 32 France Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 33 Italy Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 34 Italy Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 35 Italy Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 36 Spain Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 37 Spain Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 38 Spain Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 39 Denmark Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 40 Denmark Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 41 Denmark Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 42 Norway Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 43 Norway Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 44 Norway Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 45 Sweden Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 46 Sweden Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 47 Sweden Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Gene Therapy Cell Culture Media Market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Gene Therapy Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 52 China Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 53 China Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 54 China Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 55 Japan Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 56 Japan Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 57 Japan Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 58 India Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 59 India Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 60 India Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 61 South Korea Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 62 South Korea Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 63 South Korea Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 64 Australia Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 65 Australia Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 66 Australia Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)
  • Table 67 Thailand Gene Therapy Cell Culture Media Market, by product, 2021 - 2033 (USD Million)
  • Table 68 Thailand Gene Therapy Cell Culture Media Market, by vector type, 2021 - 2033 (USD Million)
  • Table 69 Thailand Gene Therapy Cell Culture Media Market, by end user, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 North America, Europe & Asia Pacific gene therapy cell culture media market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validation & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 North America, Europe & Asia Pacific gene therapy cell culture media market: Product outlook key takeaways
  • Fig. 19 North America, Europe & Asia Pacific gene therapy cell culture media market: Product movement analysis
  • Fig. 20 Specialty Media market, 2021 - 2033 (USD Million)
  • Fig. 21 Serum-free Media market, 2021 - 2033 (USD Million)
  • Fig. 22 Classical Media market, 2021 - 2033 (USD Million)
  • Fig. 23 Others market, 2021 - 2033 (USD Million)
  • Fig. 24 North America, Europe & Asia Pacific gene therapy cell culture media market: Vector type outlook key takeaways
  • Fig. 25 North America, Europe & Asia Pacific gene therapy cell culture media market: Vector type movement analysis
  • Fig. 26 AAV production market, 2021 - 2033 (USD Million)
  • Fig. 27 LV production market, 2021 - 2033 (USD Million)
  • Fig. 28 Other vectors market, 2021 - 2033 (USD Million)
  • Fig. 29 North America, Europe & Asia Pacific gene therapy cell culture media market: End user outlook key takeaways
  • Fig. 30 North America, Europe & Asia Pacific gene therapy cell culture media market: End user movement analysis
  • Fig. 31 Academic and research institutes market, 2021 - 2033 (USD Million)
  • Fig. 32 Pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 33 Research and Academic Institutes market, 2021 - 2033 (USD Million)
  • Fig. 34 Regional marketplace outlook, 2025 & 2033 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 North America gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 U.S. gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Canada gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Mexico gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Europe gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Germany gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 UK gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 France gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Italy gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Spain gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Denmark gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Sweden gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific gene therapy cell culture media market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Japan gene therapy cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 China gene therapy cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 India gene therapy cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 South Korea gene therapy cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Australia gene therapy cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Thailand gene therapy cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Market position analysis
  • Fig. 74 Market participant categorization
  • Fig. 75 Strategic framework